ArticleAmerican journal of audiology2022
Objective and Subjective Benefit of Direct-to-Consumer Hearing Devices in Middle-Aged Adults.
Article in American journal of audiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
purposeThe purpose of this project was to assess subjective and objective benefit provided by several direct-to-consumer hearing devices for middle-aged adults. The primary goal of this study was to determine the extent to which this type of device can yield benefit when users are listening in a range of acoustic conditions, rather than to compare benefit among devices.
methodParticipants (
resultsThe amount of objective benefit (in terms of speech recognition accuracy) varied among the four products, with two of the four devices yielding statistically significant benefit with medium-to-large effect sizes. Reduction in self-rated listening effort was noted from the use of all four devices, with a moderate effect size. Degree of hearing loss (4-frequency pure-tone average) was not significantly associated with the amount of either subjective or objective benefit. Responses to the posttask questionnaire indicated that many of the participants would be willing to use these or similar devices in the "real world."
conclusionsOur findings support the concept that direct-to-consumer hearing devices have the potential to improve objective and/or subjective speech recognition in middle-aged adults, at least when fit to prescriptive targets. Benefit from these devices was not related to degree of hearing loss in this sample of participants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.